These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 38694875)

  • 1. Disulfidptosis-related signature elucidates the prognostic, immunologic, and therapeutic characteristics in ovarian cancer.
    Cong Y; Cai G; Ding C; Zhang H; Chen J; Luo S; Liu J
    Front Genet; 2024; 15():1378907. PubMed ID: 38694875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crosstalk of disulfidptosis-related subtypes, establishment of a prognostic signature and immune infiltration characteristics in bladder cancer based on a machine learning survival framework.
    Zhao S; Wang L; Ding W; Ye B; Cheng C; Shao J; Liu J; Zhou H
    Front Endocrinol (Lausanne); 2023; 14():1180404. PubMed ID: 37152941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated analysis of disulfidptosis-related immune genes signature to boost the efficacy of prognostic prediction in gastric cancer.
    Li J; Yu T; Sun J; Ma M; Zheng Z; He Y; Kang W; Ye X
    Cancer Cell Int; 2024 Mar; 24(1):112. PubMed ID: 38528532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unveiling the hidden role of disulfidptosis in kidney renal clear cell carcinoma: a prognostic signature for personalized treatment.
    Ye Y; Zeng S; Hu X
    Apoptosis; 2024 Jun; 29(5-6):693-708. PubMed ID: 38296888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Disulfidptosis-Related LncRNA Subtypes, Establishment of a Prognostic Signature, and Characterization of Immune Infiltration in Ovarian Cancer.
    Lin J; Liu L; Cai X; Li A; Fu Y; Huang H; Sun Y
    Comb Chem High Throughput Screen; 2024 Oct; ():. PubMed ID: 39364865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signature Construction and Disulfidptosis-Related Molecular Cluster Identification for Better Prediction of Prognosis in Glioma.
    Zhuang Y; Chen J; Mai Z; Huang W; Zhong W
    J Mol Neurosci; 2024 Apr; 74(2):38. PubMed ID: 38573391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of disulfidptosis-related subtypes and development of a prognosis model based on stacking framework in renal clear cell carcinoma.
    Peng K; Wang N; Liu Q; Wang L; Duan X; Xie G; Li J; Ding D
    J Cancer Res Clin Oncol; 2023 Nov; 149(15):13793-13810. PubMed ID: 37530800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elaboration and validation of a prognostic signature associated with disulfidoptosis in lung adenocarcinoma, consolidated with integration of single-cell RNA sequencing and bulk RNA sequencing techniques.
    He D; Tang H; Yang X; Liu X; Zhang Y; Shi J
    Front Immunol; 2023; 14():1278496. PubMed ID: 37965333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel disulfidptosis-associated expression pattern in breast cancer based on machine learning.
    Wang Z; Du X; Lian W; Chen J; Hong C; Li L; Chen D
    Front Genet; 2023; 14():1193944. PubMed ID: 37456667
    [No Abstract]   [Full Text] [Related]  

  • 10. Pan-cancer genetic analysis of disulfidptosis-related gene set.
    Liu H; Tang T
    Cancer Genet; 2023 Nov; 278-279():91-103. PubMed ID: 37879141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a disulfidptosis-related genes signature for prognostic implication in lung adenocarcinoma.
    Huang J; Zhang J; Zhang F; Lu S; Guo S; Shi R; Zhai Y; Gao Y; Tao X; Jin Z; You L; Wu J
    Comput Biol Med; 2023 Oct; 165():107402. PubMed ID: 37657358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioinformatics-based analysis of the relationship between disulfidptosis and prognosis and treatment response in pancreatic cancer.
    Xiong Y; Kong X; Mei H; Wang J; Zhou S
    Sci Rep; 2023 Dec; 13(1):22218. PubMed ID: 38097783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disulfidptosis characterizes the tumor microenvironment and predicts immunotherapy sensitivity and prognosis in bladder cancer.
    Pan G; Xie H; Xia Y
    Heliyon; 2024 Feb; 10(3):e25573. PubMed ID: 38356551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel prognostic signature and immune microenvironment characteristics associated with disulfidptosis in papillary thyroid carcinoma based on single-cell RNA sequencing.
    Liao Z; Cheng Y; Zhang H; Jin X; Sun H; Wang Y; Yan J
    Front Cell Dev Biol; 2023; 11():1308352. PubMed ID: 38033866
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification and validation of immunity- and disulfidptosis-related genes signature for predicting prognosis in ovarian cancer.
    Jin M; Ni D; Cai J; Yang J
    Heliyon; 2024 Jun; 10(12):e32273. PubMed ID: 38952356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of a prognostic risk prediction model incorporating disulfidptosis-related lncRNA for patients with prostate cancer.
    Mulati Y; Lai C; Luo J; Hu J; Xu X; Kong D; Xiao Y; Liu C; Xu K
    BMC Cancer; 2024 Jan; 24(1):44. PubMed ID: 38191330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the role of the disulfidptosis-related gene SLC7A11 in adrenocortical carcinoma: implications for prognosis, immune infiltration, and therapeutic strategies.
    Liu T; Ren Y; Wang Q; Wang Y; Li Z; Sun W; Fan D; Luan Y; Gao Y; Yan Z
    Cancer Cell Int; 2023 Nov; 23(1):259. PubMed ID: 37919768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a prognostic model based on different disulfidptosis related genes typing for kidney renal clear cell carcinoma.
    Feng Y; Wang W; Jiang S; Liu Y; Wang Y; Zhan X; Zhu H; Du G
    Front Pharmacol; 2024; 15():1343819. PubMed ID: 38549669
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of disulfidptosis-associated clusters on breast cancer survival rates and guiding personalized treatment.
    Chen X; Hu G; Yu Q
    Front Endocrinol (Lausanne); 2023; 14():1256132. PubMed ID: 38116315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and validation of a disulfidptosis-related genes prognostic signature in lung adenocarcinoma.
    Zhang Y; Sun J; Li M; Hou L; Wang Z; Dong H; Xu W; Jiang R; Geng Y; Guan C; Zhu Z; Wang H; Gong Q; Zhang G
    Heliyon; 2024 Jan; 10(1):e23502. PubMed ID: 38223725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.